SWOT Analysis of AstraZeneca

SWOT analysis of AstraZenecaStrengthsAstraZeneca?s key products were Crestor, Nexium, Seroquel, Arimidex, Pulmicort, Symbicort in 2007 one-year Report. The sales of Crestor, Merrem, Seroquel increased significantly in 2007 but the reliable block-busters of the sozzled is Nexium. The community has strong focus on research and schooling; it employs 13,000 people at its research facilities, furthermore do acquisitions tie in to R&D by purchasing praise P harmaceuticals, Cambridge Antibody, Medimmune and Arrow Therapeutics. By putting emphasis on medicine research, the company invests into the future in localise to find tender components. Due to the strong monetary performance of the company it is fitting to provide the financial resources prerequisite for developing parvenu medicines and investments need to reach new commercializes. WeaknessesPatent ProtectionAs the seeming(a) protection of actual sorcerer products expire they must be replaced by new developme nts to exercise the high revenue of the firm. AstraZeneca?s need for new components deform to retain and increase its market share and competitiveness. Legal casesAstraZeneca has been fined ?60 million by the European Commission for manipulating indubitable laws to lionise competitors out of the market, marking the commencement occasion that antitrust laws cast been used to combat patent abuse (in-pharmatechnologist.com n.d.). The firm must be prepared to storage area legal questions, such as: outcomes of litigations or difficulties in obtaining and maintaining regulative approvals for new products.

There b e in possession of been legion(predicate) p! atent protection litigations in the US; Seroquel, omeprazole or Crestor in 2007 when AstraZeneca filed patent infringement suits against seven companies that submitted foreshorten new drug applications (ANDAs) seeking to market generic versions of its cholesterol drug before the patents expire. Unlucky outcome of government investigations could harm the company?s prestige, as it happened in 2003 when AstraZeneca admitted to criminal crew to vilify the Prescription Drug Marketing Act in the US. breakup of new developmentsDevelopment of... If you want to get a safe essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper